Baghrous S, Ghicha I, Bousselham F, Doussou-Yovo R, Bazhar H, Kadil Y, et al. Beyond Current Therapies: In Silico Drug Repurposing as a Strategy to Overcome Tyrosine Kinase Inhibitor Resistance in NSCLC. J. Drug Delivery Ther. [Internet]. 2025 Aug. 15 [cited 2026 Jan. 28];15(8):207-16. Available from: https://jddtonline.info/index.php/jddt/article/view/7276